文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

核壳型咪唑啉功能化介孔硅超顺磁杂化纳米粒子作为一种潜在的治疗诊断试剂用于铂(II)化合物的控制释放。

Core-Shell Imidazoline-Functionalized Mesoporous Silica Superparamagnetic Hybrid Nanoparticles as a Potential Theranostic Agent for Controlled Delivery of Platinum(II) Compound.

机构信息

Department of Pharmaceutical Nanotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.

Center for Nanotechnology in Drug Delivery, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.

出版信息

Int J Nanomedicine. 2020 Apr 20;15:2617-2631. doi: 10.2147/IJN.S245135. eCollection 2020.

DOI:10.2147/IJN.S245135
PMID:32368044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7182466/
Abstract

INTRODUCTION: As widely used chemotherapeutic agents, platinum compounds have several therapeutic challenges, such as drug resistance and adverse effects. Theranostic systems, macromolecular or colloidal therapeutics with companion diagnostics, not only address controlled drug delivery but also enable real-time monitoring of tumor sites. METHODS: Synthesis of magnetic mesoporous silica nanoparticles (MMSNs) was performed for dual magnetic resonance imaging and drug delivery. MMSN surfaces were modified by imidazoline groups (MMSN-Imi) for cisplatin (Cis-Pt) conjugation via free N-termini to achieve well-controlled drug-release kinetics. Cis-Pt adsorption isotherms and drug-release profile at pH 5 and 7.4 were investigated using inductively coupled plasma atomic emission spectroscopy. RESULTS: MMSN-Imi showed a specific surface area of 517.6 m g, mean pore diameter of 3.26 nm, and saturated magnetization of 53.63 emu/g. A relatively high r/r relaxivity value was obtained for MMSN-Imi. The nanoparticles provided high Cis-Pt loading with acceptable loading capacity (~30% w:w). Sustained release of Cis-Pt under acidic conditions led to specific inhibitory effects on the growth of human epithelial ovarian carcinoma cells, determined using MTT assays. Dual acridine orange-propidium iodide staining was investigated, confirming induction of apoptosis and necrotic cell death. CONCLUSION: MMSN-Imi exhibited potential for applications in cancer chemotherapy and combined imaging.

摘要

简介：铂类化合物作为广泛应用的化疗药物，存在耐药性和不良反应等治疗挑战。治疗诊断系统，即具有伴随诊断的大分子或胶体治疗剂，不仅可以解决药物控释问题，还可以实现肿瘤部位的实时监测。

方法：合成了用于双重磁共振成像和药物递送的磁性介孔硅纳米粒子（MMSNs）。通过自由 N 末端将咪唑啉基团（MMSN-Imi）修饰到 MMSN 表面，用于顺铂（Cis-Pt）的共轭，以实现对药物释放动力学的良好控制。使用电感耦合等离子体原子发射光谱法研究了 Cis-Pt 吸附等温线和在 pH 5 和 7.4 下的药物释放曲线。

结果：MMSN-Imi 的比表面积为 517.6 m²/g，平均孔径为 3.26nm，饱和磁化强度为 53.63 emu/g。MMSN-Imi 的 r/r 弛豫率值相对较高。纳米粒子提供了高的 Cis-Pt 负载量，具有可接受的载药能力（约 30%w/w）。在酸性条件下持续释放 Cis-Pt 导致对人上皮性卵巢癌细胞生长的特异性抑制作用，通过 MTT 测定证实。进行了双重吖啶橙-碘化丙啶染色，证实了诱导细胞凋亡和坏死性细胞死亡。

结论：MMSN-Imi 具有应用于癌症化学治疗和联合成像的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/cdab7fda7d46/IJN-15-2617-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/117acc7dd5bf/IJN-15-2617-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/a364782af5c5/IJN-15-2617-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/8961c8e48fe2/IJN-15-2617-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/4a4131477c89/IJN-15-2617-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/7d50773492e1/IJN-15-2617-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/ae5bab592259/IJN-15-2617-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/d80bc4912f69/IJN-15-2617-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/d96418a58389/IJN-15-2617-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/cdab7fda7d46/IJN-15-2617-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/117acc7dd5bf/IJN-15-2617-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/a364782af5c5/IJN-15-2617-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/8961c8e48fe2/IJN-15-2617-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/4a4131477c89/IJN-15-2617-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/7d50773492e1/IJN-15-2617-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/ae5bab592259/IJN-15-2617-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/d80bc4912f69/IJN-15-2617-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/d96418a58389/IJN-15-2617-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec65/7182466/cdab7fda7d46/IJN-15-2617-g0009.jpg

相似文献

[1]
Core-Shell Imidazoline-Functionalized Mesoporous Silica Superparamagnetic Hybrid Nanoparticles as a Potential Theranostic Agent for Controlled Delivery of Platinum(II) Compound.

Int J Nanomedicine. 2020-4-20

[2]
Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by FeO/carboxyl functionalized mesoporous SiO hybrid nanoparticles: A-synthesis, physicochemical and biological characterization.

Mater Sci Eng C Mater Biol Appl. 2019-6-27

[3]
Synthesis and properties of magnetic nanotheranostics coated with polyethylene glycol/5-fluorouracil/layered double hydroxide.

Int J Nanomedicine. 2019-8-19

[4]
Theranostic magnetite cluster@silica@albumin double-shell particles as suitable carriers for water-insoluble drugs and enhanced T2 MR imaging contrast agents.

Mater Sci Eng C Mater Biol Appl. 2019-2-16

[5]
Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer.

J Drug Target. 2020-1

[6]
Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application.

Dalton Trans. 2018-3-26

[7]
Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery.

Colloids Surf B Biointerfaces. 2014-5-1

[8]
Zinc oxide end-capped FeO@mSiO core-shell nanocarriers as targeted and responsive drug delivery system for chemo-/ions synergistic therapeutics.

Drug Deliv. 2019-12

[9]
Synthesis of biocompatible, mesoporous Fe(3)O(4) nano/microspheres with large surface area for magnetic resonance imaging and therapeutic applications.

ACS Appl Mater Interfaces. 2011-1-13

[10]
Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.

Molecules. 2018-11-26

引用本文的文献

[1]
The Application of Mesoporous Silica Nanoparticles in Enhancing the Efficacy of Anti-Atherosclerosis Therapies: A Review.

Int J Nanomedicine. 2025-8-10

[2]
Mesoporous Silica Administration as a New Strategy in the Management of Warfarin Toxicity: An In-Vitro and In-Vivo Study.

Adv Pharm Bull. 2024-12-30

[3]
Immobilization of L-Asparaginase on biofunctionalized magnetic graphene oxide nanocomposite: A promising approach for Enhanced Stability and reusability.

Heliyon. 2024-11-1

[4]
Magnetic graphene oxide nanosheets with amidoamine dendronized crosslinks for dual pH and redox-sensitive doxorubicin delivery.

BMC Chem. 2024-9-28

[5]
Synthesis and evaluation of cross-linked tragacanthin nanofibers as implants for delivery of cisplatin to hepatocellular carcinoma.

Heliyon. 2024-8-31

[6]
Smart and Multi-Functional Magnetic Nanoparticles for Cancer Treatment Applications: Clinical Challenges and Future Prospects.

Nanomaterials (Basel). 2022-10-12

[7]
Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics.

Pharmaceutics. 2022-2-25

[8]
Synthesis of Pore-Size-Tunable Mesoporous Silica Nanoparticles by Simultaneous Sol-Gel and Radical Polymerization to Enhance Silibinin Dissolution.

Iran J Med Sci. 2021-11

[9]
Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview.

Int J Mol Sci. 2021-8-26

[10]
Mesoporous Silica Particles as Drug Delivery Systems-The State of the Art in Loading Methods and the Recent Progress in Analytical Techniques for Monitoring These Processes.

Pharmaceutics. 2021-6-24

本文引用的文献

[1]
Impact of mesoporous silica nanoparticle surface functionality on hemolytic activity, thrombogenicity and non-specific protein adsorption.

J Mater Chem B. 2013-4-14

[2]
Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by FeO/carboxyl functionalized mesoporous SiO hybrid nanoparticles: A-synthesis, physicochemical and biological characterization.

Mater Sci Eng C Mater Biol Appl. 2019-6-27

[3]
Simulation-guided photothermal therapy using MRI-traceable iron oxide-gold nanoparticle.

J Photochem Photobiol B. 2019-8-22

[4]
Interpreting non-linear drug diffusion data: Utilizing Korsmeyer-Peppas model to study drug release from liposomes.

Eur J Pharm Sci. 2019-7-30

[5]
Preparation of injectable temperature-sensitive chitosan-based hydrogel for combined hyperthermia and chemotherapy of colon cancer.

Carbohydr Polym. 2019-6-28

[6]
Loading of Cisplatin into Mesoporous Silica Nanoparticles: Effect of Surface Functionalization.

Langmuir. 2019-6-22

[7]
Gold-decorated magnetic nanoparticles design for hyperthermia applications and as a potential platform for their surface-functionalization.

Sci Rep. 2019-3-12

[8]
Nanoenabled Bioseparations: Current Developments and Future Prospects.

Biomed Res Int. 2019-1-29

[9]
Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels.

Int J Nanomedicine. 2018-10-9

[10]
Synthesis, structural and in-vitro characterization of β-cyclodextrin grafted L-phenylalanine functionalized graphene oxide nanocomposite: A versatile nanocarrier for pH-sensitive doxorubicin delivery.

Carbohydr Polym. 2018-8-17

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索